ASSET PURCHASE AGREEMENT By and Among PHIBRO ANIMAL HEALTH CORPORATION, as Purchaser OSPREY BIOTECHNICS, INC. as Company and together with LAUREN DANIELSON and VINCENT SCUILLA as Selling Parties August 1, 2019Asset Purchase Agreement • November 4th, 2019 • Phibro Animal Health Corp • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AGREEMENT (as the same shall be amended, modified or supplemented, this “Agreement”) dated as of August 2, 2019 (the “Effective Date” or “the date hereof”) by and between Osprey Biotechnics, Inc., a Florida corporation (“Company”), Lauren Danielson, an individual (“Danielson”), and Vincent Scuilla (“Scuilla,” and collectively with Danielson, “Stockholders”), and Phibro Animal Health Corporation, a Delaware corporation (together with its permitted successors and assigns, “Purchaser”). Company and Stockholders are referred to herein collectively as “Selling Parties.”
